Anna Bashmakova

EastHORN - A Novotech Company

EastHORN is now a Novotech company and will integrate all systems and processes, so clients benefit from working with one CRO globally. Experienced in Phase I to Phase IV studies across all therapeutic areas including Neurology & Psychiatry, Oncology, Cardiovascular Diseases, Infectious & Parasitic Diseases and Gastrointestinal Diseases. The large and diverse patient populations also make this region an ideal location for rare disease studies. EastHORN has over 250 employees and a presence in virtually every European country. Established in 2004 and boasting a highly experienced management team, EastHORN provides a high quality service combined with the rapid recruitment for which this region is renowned. EastHORN is ISO 9001:2015 certified for the Quality Management System.